Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meryem Bektas

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Managed Care & Specialty Pharmacy|December 28, 2020
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needsMeryem Bektas, Catherine Copley-Merriman, Shahnaz Khan, et al.
The Journal of Cell Biology|June 9, 2005
A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cellsMeryem Bektas, Shawn G Payne, Hong Liu, et al.
JPMA. the Journal of the Pakistan Medical Association|August 20, 2024
Kinesiophobia, physical activity levels and barriers in breast cancer patients, survivors, and healthy controls: A case-control analysisNuray Alaca, Kubra Turker Karayazi, Dilek Cagri Arslan, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2020
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiologyMeryem Bektas, Catherine Copley-Merriman, Shahnaz Khan, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2020
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of diseaseMeryem Bektas, Catherine Copley-Merriman, Shahnaz Khan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 18, 2024
Disparities in Respiratory Syncytial Virus Risk Factors, Diagnosis, and Outcomes in Adults by Race, Ethnicity, and Other Social Determinants of Health in the United StatesEmily K Horn, Elizabeth M La, Meryem Bektas, et al.
Journal of Managed Care & Specialty Pharmacy|May 1, 2023
Geographic atrophy: Mechanism of disease, pathophysiology, and role of the complement systemSophie J Bakri, Meryem Bektas, Darcie Sharp, et al.
Cancer Chemotherapy and Pharmacology|July 15, 2009
A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cellsMeryem Bektas, Stewart P Johnson, William E Poe, et al.
Oncogene|January 8, 2005
Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expressionMeryem Bektas, Puneet S Jolly, Carola Müller, et al.
Infectious Diseases and Therapy|April 23, 2025
A Systematic Literature Review of the Epidemiology of Complicated Urinary Tract InfectionEdward Broughton, Meryem Bektas, Ann Colosia, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Managed Care & Specialty Pharmacy|December 28, 2020
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needsMeryem Bektas, Catherine Copley-Merriman, Shahnaz Khan, et al.
The Journal of Cell Biology|June 9, 2005
A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cellsMeryem Bektas, Shawn G Payne, Hong Liu, et al.
JPMA. the Journal of the Pakistan Medical Association|August 20, 2024
Kinesiophobia, physical activity levels and barriers in breast cancer patients, survivors, and healthy controls: A case-control analysisNuray Alaca, Kubra Turker Karayazi, Dilek Cagri Arslan, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2020
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiologyMeryem Bektas, Catherine Copley-Merriman, Shahnaz Khan, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2020
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of diseaseMeryem Bektas, Catherine Copley-Merriman, Shahnaz Khan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 18, 2024
Disparities in Respiratory Syncytial Virus Risk Factors, Diagnosis, and Outcomes in Adults by Race, Ethnicity, and Other Social Determinants of Health in the United StatesEmily K Horn, Elizabeth M La, Meryem Bektas, et al.
Journal of Managed Care & Specialty Pharmacy|May 1, 2023
Geographic atrophy: Mechanism of disease, pathophysiology, and role of the complement systemSophie J Bakri, Meryem Bektas, Darcie Sharp, et al.
Cancer Chemotherapy and Pharmacology|July 15, 2009
A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cellsMeryem Bektas, Stewart P Johnson, William E Poe, et al.
Oncogene|January 8, 2005
Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expressionMeryem Bektas, Puneet S Jolly, Carola Müller, et al.
Infectious Diseases and Therapy|April 23, 2025
A Systematic Literature Review of the Epidemiology of Complicated Urinary Tract InfectionEdward Broughton, Meryem Bektas, Ann Colosia, et al.
Pageof 4